XCUR

Exicure (XCUR)

About Exicure (XCUR)

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Details

Daily high
$6.32
Daily low
$5.63
Price at open
--
52 Week High
$22.99
52 Week Low
$3.10
Market cap
36.5M
Dividend yield
0.00%
Volume
2
Avg. volume
2.1M
P/E ratio
-3.81

Exicure News

Details

Daily high
$6.32
Daily low
$5.63
Price at open
--
52 Week High
$22.99
52 Week Low
$3.10
Market cap
36.5M
Dividend yield
0.00%
Volume
2
Avg. volume
2.1M
P/E ratio
-3.81